Horizon, Boehringer team on oncology research, 2/13:109

Create PDF

Horizon will also apply its Genesis genome editing technology to develop human isogenic disease model cell lines, according to Boehringer’s specifications. Using Genesis, Horizon can alter any endogenous gene sequence of human or mammalian cell lines quickly, reliably, and without unwanted and confounding genotypes or phenotypes. The resulting high-quality cell lines accurately model the disease-causing mutations found in patients.

Horizon Discovery, 44(0)12 2365 5580

Boehringer Ingelheim, 203-798-9988